Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Salivary Glands Tumors × Abiraterone Acetate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 83 Neoplasm Metastasis 7 Prostatic Neoplasms, Castration-Resistant 5 Breast Neoplasms 3 Neoplasms 2 Urinary Bladder Neoplasms 1 Stage II Prostate Adenocarcinoma 1 Salivary Glands Tumors 1 Prostate Cancer Metastatic 1 Prostate Adenocarcinoma 1 Oligometastatic Prostate Carcinoma 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 NSCLC Harboring NRG1 Fusion 1 Metastatic Hormone-sensitive Prostate Cancer (mHSPC) 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castration Resistant Prostate Cancer 1 Hyperaldosteronism 1 Cushing Syndrome 1 Castration-resistant Prostate Cancer 1 Carcinoma, Transitional Cell 1 Adrenocortical Carcinoma 1 Adenocarcinoma 1

Interventions

Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02867852 2021-03-03

SG-ABI14

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Completed

Salivary Glands Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡